Skip to main content

Recent News

Enhance your clinical practice with insights from the EULAR 2024 Poster Hall Presentations, now on https://t.co/V10S4oVFsv. This year's conference showcases pivotal research in rheumatology. Visit https://t.co/58cJsSROsE to stay at the forefront of medical innovation. https://t.co/jbbufRQ6MW
Dr. John Cush @RheumNow (  View Tweet)
Rituximab vs. Tocilizimab for Scleroderma: Which is Better? Dr. Janet Pope discusses abstract OP0295 presented at Eular 2024 in Vienna, Austria. https://t.co/70YF2wxwj5 https://t.co/8BHCafFs3u
Dr. John Cush @RheumNow (  View Tweet)
Has JAK POT Hit the Spot About Infection Risk? Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria. https://t.co/vN2VZYGqbE https://t.co/MQ3QCJU4SW
Dr. John Cush @RheumNow (  View Tweet)
Does Withdrawing Steroids Increase Flares in SLE? Dr. Janet Pope reports on abstract OP0180 presented at Eular 2024 in Vienna, Austria. https://t.co/FjS0MBeWkv https://t.co/jeoO0gzz0K
Dr. John Cush @RheumNow (  View Tweet)
DMARDs and Herpes Zoster Vaccination: To Stop or Not To Stop Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria. https://t.co/gKJRygBeq0 https://t.co/2NTNYJLPNZ
Dr. John Cush @RheumNow (  View Tweet)
Damage in Childhood Lupus Childhood lupus (cSLE) is a rare multisystem disorder with significant associated morbidity, but evidence-based guidelines are sparse, and as such management is often based on clinical expertise. https://t.co/wCygK0LGvd https://t.co/tm8LTI28mh
Dr. John Cush @RheumNow (  View Tweet)
RA: update for women of child bearing potential (and men!) Fertility in the context of RMDs is a daily concern for a lot of rheumatologists and patients. https://t.co/RrkR2V3CI3 https://t.co/CRXUKxUqF2
Dr. John Cush @RheumNow (  View Tweet)
Difficult-to-treat Rheumatoid Arthritis: Validation of the EULAR Definition Dr. Mrinalini Dey discusses abstract OP0156 presented at Eular 2024 in Vienna, Austria. https://t.co/oc3Aj60KsM https://t.co/40FMjbKEHF
Dr. John Cush @RheumNow (  View Tweet)
EULAR 2024 Daily Recap: Days 1 & 2 Dr. Jack Cush moderates EULAR 2024 RECAP for days 1 & 2 with Drs. Mrinalini Day and Yuz Yusof in Vienna, Austria. https://t.co/gRMVUXhTxw https://t.co/YV8vjVUCJn
Dr. John Cush @RheumNow (  View Tweet)
Rituximab to Treat Systemic Features of Sjogren's Dr. Yuz Yusof discusses abstract OP0076 presented at Eular 2024 in Vienna, Austria. https://t.co/9oJNz12cCI https://t.co/bZxpbf3PT9
Dr. John Cush @RheumNow (  View Tweet)
Update on Sjogren's disease trials With better endpoint and patient selection strategy over the last 4 years, many new therapies have met their endpoints/shown promising signal in the Phase 2 RCTs in Sjogren's disease. https://t.co/qMxEX73BsM https://t.co/CQWaAIO4IK
Dr. John Cush @RheumNow (  View Tweet)
New Treatments for Systemic Sclerosis aHSCT for SSc has been proven the most effective treatment strategy with regard to overall and event free survival in selected patients.2 But a key limitation is its toxicity, and new treatment options are needed. https://t.co/xUI0plrk42 https://t.co/DqGUhU6D1Z
Dr. John Cush @RheumNow (  View Tweet)
Camels and psoriatic arthritis - a new treatment link https://t.co/0SQt3UPmKu https://t.co/zvwH9iYtxX
Dr. John Cush @RheumNow (  View Tweet)
EULAR 2024 – Day 4 Report The final day of EULAR 2024 was rich in posters, Late-breaking oral presentations and EULAR updates and recommendations. Below is a synopsis of the half-day's action. https://t.co/1lQcu1beOm https://t.co/QHMcFzaG48
Dr. John Cush @RheumNow (  View Tweet)
We've Got to Talk about CAR T cells Dr. Yuz Yusof discusses abstract OP0017 presented at the Eular 2024 meeting in Vienna, Austria. https://t.co/mrr5MWxeJz https://t.co/0FMLaAxaWV
Dr. John Cush @RheumNow (  View Tweet)
Select your GCA Therapy Dr. David Liew discusses LBA0001 presented at Eular 2024 in Vienna, Austria. https://t.co/TPBeU7KaEq https://t.co/09uEzM3Kkd
Dr. John Cush @RheumNow (  View Tweet)
Predicting Palindromic Prognosis Dr. David Liew discusses abstract OP0127 at Eular 2024 in Vienna, Austria. https://t.co/Nc0XymI24l https://t.co/69qdLh63ct
Dr. John Cush @RheumNow (  View Tweet)
Giant Cell Arteritis and Polymyalgia Rheumatica Update Dr. Janet Pope discusses abstracts LBA0001, OP0233, OP0261 and POS0280 at Eular 2024 in Vienna, Austria. https://t.co/0V9Sle0GMU https://t.co/ixeT8L562C
Dr. John Cush @RheumNow (  View Tweet)
Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria. https://t.co/mv9DeZ9cez https://t.co/1OpT3MomO8
Dr. John Cush @RheumNow (  View Tweet)
Update on low-dose glucocorticoids in SLE GC have been the mainstay of treatment in SLE for nearly 75 yrs. GC induce anti-inflammatory effects, quickly relieve symptoms, and reduce mortality in life-threatening flares through various actions. https://t.co/uEtWftvwEz https://t.co/nJlpELMj5W
Dr. John Cush @RheumNow (  View Tweet)